| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |